Implementing a Shingles Protocol in Pharmacies


William Schaffner, MD
Professor of Preventive Medicine, Department of Health Policy
Professor of Medicine, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN
William Schaffner, MD

Dr. William Schaffner is Professor of Preventive Medicine in the Department of Health Policy and Professor of Infectious Diseases at the Vanderbilt University School of Medicine, Nashville, Tennessee.

Dr. Schaffner’s primary focus has been the prevention of infectious diseases. He is a strong proponent of collaboration between academic medical centers and public health institutions. He has worked extensively on the effective use of vaccines and has been a member of expert advisory committees that establish national vaccine policy.

Dr. Schaffner is committed to the communication of disease prevention with the general public and regards this as a teaching opportunity. He is often invited to comment on communicable disease issues on local and national media, translating research and public health events into language that the public can understand.

After graduating from Yale in 1957, Schaffner attended the University of Freiburg, Germany as a Fulbright Scholar. He graduated from Cornell University Medical College in 1962 and completed residency training and a Fellowship in Infectious Diseases at Vanderbilt. He was commissioned in the U.S. Public Health Service as an Epidemic Intelligence Service Officer with the Centers for Disease Control and Prevention (CDC) for two years. He returned to Vanderbilt after that tour of duty and established a long collaboration with the Tennessee Department of Health and the CDC.

Michael D. Hogue, PharmD, FAPhA, FNAP
Dean and Professor, Loma Linda University School of Pharmacy, Loma Linda, CA
Michael D. Hogue, PharmD, FAPhA, FNAP

Michael D. Hogue is the current Dean and Professor of Loma Linda University School of Pharmacy, Loma Linda, California. He serves as the 165th president of the American Pharmacists Association (APhA) and is the immediate past Speaker of the House of Delegates of APhA. Throughout his career, Dr. Hogue has served many different roles in pharmacy practice, including owning an independent community pharmacy and home infusion company, working in a chain community pharmacy, and later as an ambulatory care pharmacist in family practice medicine.

Dr. Hogue was on the staff development team and an original national faculty member for APhA’s Pharmacy-Based Immunization Delivery national certificate program for pharmacists, which over 350,000 pharmacists and student pharmacists have completed since its inception in 1996. He continues to be actively engaged in immunization policy and advocacy in pharmacy, as well as education of nurse practitioners and physicians in disease prevention through vaccines. He has conducted several studies in the area of vaccine implementation through pharmacies, written dozens of manuscripts and monographs related to vaccines and vaccine preventable diseases and speaks frequently around the globe on the subject. Dr. Hogue was the first pharmacist in the state of Alabama to administer vaccines in his pharmacy practice in 1997.

Dr. Hogue holds a Bachelor’s in Pharmacy and a PharmD degree from Samford University, Birmingham, Alabama. As a student, he became very involved in the pharmacist recovery network movement and served as the editor and author on a book to assist schools and colleges of pharmacy in dealing with drug and alcohol abuse within the profession. As a practitioner and later as president of APhA’s Academy of Pharmacy Practice and Management, Hogue led or served on several sentinel groups to move the recognition of pharmacists forward, including the Pharmacy Services Technical Advisory Committee (PSTAC) to the American Medical Association, and the consensus group which was assigned with the responsibility of defining Medication Therapy Management Services. He subsequently published with APhA the profession’s first two books on payment for pharmacist’s non-dispensing services.

Statement of Need

Shingles, or herpes zoster, is a common secondary infection that can impose a significant burden, impacting cerebrovascular, cardiovascular, neurologic, ophthalmic, and dermatologic systems. Therefore, despite common perceptions, shingles is more than just a rash, and its extensive burden highlights the need for an effective prevention strategy. While highly effective vaccines exist, shingles vaccination remains low. Community pharmacists play a critical role in educating at-risk patients about shingles and the availability of vaccines to prevent shingles-related complications, as well as easing the accessibility of shingles vaccination. However, barriers may impede the implementation of shingles vaccination protocols in community pharmacy settings.

This CMEOCast podcast features expert faculty focusing on best practices to increase vaccine uptake by engaging and educating patients in pharmacy settings.

Learning Objectives

At the end of this CME/CE activity, participants should be able to develop best practices to implement a shingles protocol in pharmacy settings.

The following learning objectives pertain only to those requesting CNE or CPE credit: Describe best practices for a shingles protocol in pharmacy settings.

Financial Support

This educational activity is supported by an educational grant from GlaxoSmithKline.

Target Audience

Physicians, PAs, nurse practitioners, and pharmacists.

Credit Information

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists/Pharmacy Tech (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.
Activity UAN: 0376-0000-20-133-H06-P


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit  from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Schaffner has no disclosures to report.

Michael D. Hogue, PharmD, FAPhA, FNAP has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

  • Michael J. Franks, MSN, AGACNP-BC, FNP-BC (peer reviewer)
  • Mae Ochoa, RPh (peer reviewer)
  • Kashemi D. Rorie, PhD (planning committee)
  • Evan Luberger (planning committee)
  • Jan Perez (planning committee)
  • Sharon Tordoff (planning committee)


Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Additional Formats

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.


NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-20-133-H06-P.



Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).


Implementing a Shingles Protocol in Pharmacies
Event Date: 10/29/2020